NASDAQ:STAB Statera Biopharma (STAB) Stock Price, News & Analysis → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free STAB Stock Alerts $0.0006 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.00▼$0.04Volume1,030 shsAverage Volume32,501 shsMarket Capitalization$32,796.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Get Statera Biopharma alerts: Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. About Statera Biopharma Stock (NASDAQ:STAB)Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.Read More STAB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STAB Stock News HeadlinesFebruary 25, 2024 | wsj.comAEON Biopharma Inc.January 30, 2024 | investing.comMereo BioPharma Group PLC ADR (MREO)March 29, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.December 14, 2023 | bbc.comCrookes curry house knife used to stab teenager to deathDecember 9, 2023 | bbc.comLeeds stab death: Police name victim of Chapeltown attackNovember 25, 2023 | bbc.co.ukTwo boys, 12, in court charged with Wolverhampton stab murderNovember 25, 2023 | bbc.co.ukWolverhampton: Two boys, 12, arrested over stab murder of manNovember 11, 2023 | morningstar.comARCA biopharma Inc ABIOMarch 29, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.November 10, 2023 | nbcnews.comCornell University student threatened to stab and rape Jewish students and ‘shoot up’ school, prosecutors sayOctober 31, 2023 | morningstar.comPOINT Biopharma Global Inc Ordinary Shares PNTOctober 29, 2023 | nypost.comElianne Andam died from ‘multiple stab wounds’ in ‘brutal’ attackOctober 23, 2023 | benzinga.comSutro Biopharma Stock (NASDAQ:STRO), Analyst Ratings, Price Targets, PredictionsOctober 12, 2023 | bbc.comMurder arrest over man's stab death in HaringeyOctober 11, 2023 | mirror.co.ukBristol stab death victim's family 'heartbroken' as woman in 'hate crime' arrestOctober 6, 2023 | bbc.co.ukHigh Wycombe: Two men held over teen's stab deathJuly 31, 2023 | mirror.co.ukChilling moment teen killers stab wrong boy with ninja sword in mistaken identity murderMay 7, 2023 | abcnews.go.comAutopsy: Stab wounds to heart, lungs killed Cash App founderMay 2, 2023 | news.yahoo.com‘Don’t let him stab him:’ Police release video of suspect shot, killed attempting to stab police K-9March 15, 2023 | finance.yahoo.comStatera Biopharma Signs Letter of Intent for Merger with Worksite LabsJanuary 27, 2023 | seekingalpha.comSTAB Statera Biopharma, Inc.January 24, 2023 | finanznachrichten.deStatera Biopharma Announces Completion of Application Process to Uplist to the OTCQB Venture MarketplaceJanuary 24, 2023 | finance.yahoo.comStatera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture MarketplaceOctober 27, 2022 | finance.yahoo.comStatera Biopharma Receives Positive Nasdaq Listing DeterminationOctober 24, 2022 | msn.comWhy Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From FridayOctober 21, 2022 | finance.yahoo.comStatera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOFOctober 21, 2022 | benzinga.comWhy Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving PremarketSee More Headlines Receive STAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Statera Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:STAB CUSIPN/A CIK1318641 Webwww.staterabiopharma.com Phone(888) 613-8802Fax716-849-6820Employees46Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.49 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares54,660,000Free Float51,656,000Market Cap$32,796.00 OptionableNot Optionable Beta0.49 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Michael Kevin Handley (Age 52)CEO, President & Chairman of the Board Comp: $2.87MMr. Christopher Zosh (Age 48)Executive VP of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer Dr. Robert W. Buckheit Jr. (Age 64)Ph.D., Chief Technology Officer Key CompetitorsNovanNASDAQ:NOVNNVN LiquidationNASDAQ:NOVNQScopus BioPharmaNASDAQ:SCPSHumanigenNASDAQ:HGENIgnyte AcquisitionNASDAQ:IGNYView All Competitors STAB Stock Analysis - Frequently Asked Questions How have STAB shares performed in 2024? Statera Biopharma's stock was trading at $0.0006 at the beginning of 2024. Since then, STAB shares have increased by 0.0% and is now trading at $0.0006. View the best growth stocks for 2024 here. How do I buy shares of Statera Biopharma? Shares of STAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:STAB) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Statera Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.